Stockwire
• Wealth Insight - Mar 2024
vis-a-vis: Cipla vs Dr Reddy's Labs
Putting two market leaders face-to-face
01-Mar-2024•Value Research
Top Picks
What Small Caps Actually Pay You For
12 min read•By Ruchira Sharma
Welcome to the New Value Research!
2 min read•By Value Research
New episodes every Friday
Buying the fund house
Judging listed fund houses by the metric that matters most
Other Episodes
-
Growth that goes nowhere
Why every growing company isn't making its shareholders richer
-
A fall is not a loss
A red number on your screen is not a loss. You make it permanent only by acting on it.
-
The question you didn't ask
Why the best investors check lists, not just conviction
-
The AI bubble question
Whether AI is a bubble matters less than whether you are behaving like one
More stories from Wealth Insight March 2024
Explore the edition
'Monkey see, monkey do' won't do
3 min read•By Dhirendra Kumar
Cover Story: Imitation investing
19 min read•By Value Research
Market Reporter - Newsmakers of February 2024
1 min read•By Value Research
Stock Story: From Lakmé to Zudio
1 min read•By Value Research
Big moves of the past three months
1 min read•By Value Research
IPO corner: A snapshot into D-Street debutants
1 min read•By Value Research
Market Barometer: Is the market overvalued?
1 min read•By Value Research
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
